Skip to content

Occurrence of venous thromboembolism after thoracic surgery in patients receiving thrombosis prophylaxis with 40mg enoxaparin. Study 1: Occurrence of venous thrombus embolism after anatomical lung resection in patients with lung cancer

Occurrence of venous thromboembolism after thoracic surgery in patients receiving thrombosis prophylaxis with 40mg enoxaparin. Study 1: Occurrence of venous thrombus embolism after anatomical lung resection in patients with lung cancer - VETEAS-1. Veneous Thrombembolies After (Thoracic) Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020525
Enrollment
133
Registered
2020-01-23
Start date
2020-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I26 I80 C34

Interventions

Group 1: Single arm study. On the 3rd and 7th postoperative day a blood sample is taken for the determination of the anti-factor Xa level as well as a duplex ultrasound of the leg veins is performed.

Sponsors

Lungenklinik,Kliniken der Stadt Köln gGmbH, Uniklinik der Privaten Universität Witten/Herdecke
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age = 40 years - Indication for anatomical lung resection - Detected or suspected lung carcinoma - Information and signed consent - The use of antiplatelet drugs (e.g. ASS, Clopidogrel) is permitted

Exclusion criteria

Exclusion criteria: - VTE in medical history within the last 12 months - severe coagulation disorder (PTT > 40s, Quick 1.5, thrombocytes 1.15 mg/dl for men and 0.95 mg/dl for women) - Known coagulopathy - Existing drug anticoagulation - Contrast agent allergy - Hyperthyroidism - Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Rate of patients with adequate prophylactic anti factor Xa level (0.3 - 0.5 U/ml) on the 3rd postoperative day reciving VTE prophylaxis with 40mg enoxaparin

Secondary

MeasureTime frame
- Rate of postoperative deep vein thrombosis - Rate of postoperative pulmonary embolisms - Rate of postoperative venous thrombembolisms - Influence of anti-factor Xa level on the incidence of venous thrombembolism - Influence of patient characteristics (BMI, gender, renal function) on antifactor Xa activity and incidence of venous thrombembolism - Postoperative complications, especially intra- and postoperative bleeding

Countries

Germany

Contacts

Public ContactAlberto Lopez

St. Hildegardis Krankenhaus, Thoraxklinik

alopez@sthildegardis.de022140038173

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026